ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2018 American Transplant Congress

    Comprehensive Validation of Different Clinical Prediction Models on Short- and Long-Term Outcome Following Orthotopic Liver Transplantation

    J. Boecker,1 Z. Czigany,1 J. Bednarsch,1 I. Amygdalos,1 F. Meister,1 D. Morales Santana,1 W. Schoening,1 T. Ulmer,1 M. Krebbers,1 G. Koek,1 D. Kroy,2 F. Tacke,2 C. Trautwein,2 U. Neumann,1 G. Lurje.1

    1Department of Surgery and Transplantation, University Hospital RWTH, Aachen, Germany; 2Department of Internal Medicine III, University Hospital RWTH, Aachen, Germany.

    Background: Organ shortage remains a major problem in orthotopic liver transplantation (OLT). An optimal utilization of the donor pool with better prediction of outcome is…
  • 2018 American Transplant Congress

    Does DGF Result in Worse Outcomes in a Second Transplant?

    B. Muth,1 B. Astor,1,2 J. Blazel,1 J. Turk,1 D. Mandelbrot,1 A. Djamali,1 S. Parajuli.1

    1Department of Medicine, University of Wisconsin, Madison, WI; 2Department of Population Health, University of Wisconsin, Madison, WI.

    Delayed graft function (DGF) is a risk factor for patient death, kidney allograft loss, reduced allograft function and acute rejection after kidney transplantation. Prior transplant…
  • 2018 American Transplant Congress

    Infectious Complications Associated with Eculizumab Used for ABO-Incompatible Renal Transplantation

    M. Campara, P. West-Thielke, K. Progar, N. Jasiak, A. Lichvar, I. Tang, E. Benedetti.

    University of Illinois at Chicago, Chicago.

    Introduction: A novel approach in ABO-incompatible (ABOi) living donor renal transplant (LDRT) includes use of eculizumab (ECU) that allows for avoidance of traditional desensitization. We…
  • 2018 American Transplant Congress

    The AKI-Predict-Score: A New Prediction Model for Acute Kidney Injury after Liver Transplantation

    M. Kalisvaart,1 A. Schlegel,1 I. Umbro,2 K. Roberts,1 D. Mirza,1 T. Perera,1 J. Isaac,1 A. P. Mitterhofer,2 J. de Jonge,3 P. Muiesan.1

    1Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom; 2Internal Medicine, Sapienza University, Rome, Italy; 3Surgery, Erasmus MC University Medical Center, Rotterdam, Netherlands.

    BackgroundPostoperative acute kidney injury (AKI) is a frequent complication after liver transplantation and associated with impaired survival rates, chronic kidney disease and higher costs. Although…
  • 2017 American Transplant Congress

    Long Wait Time Regions for Liver Transplantation for HCC Have a Higher Cumulative Incidence of Death.

    R. Hogen, J. Dinorcia, M. Lo, B. Nguyen, Y. Genyk, L. Sher, K. Dhanireddy.

    Abdominal Transplantation, University of Southern California, Los Angeles, CA

    Purpose: To determine the effect of regional variability in wait timeon survival of patients with hepatocellular carcinoma(HCC) listed for deceased donor liver transplantation(DDLT).Methods: Patients age>18…
  • 2017 American Transplant Congress

    Post-Donation Experiences of Non-Directed (Altruistic) Living Kidney Donors in the United States.

    A. Maghen,1 G. Vargas,1 S. Connor,1 S. Nassiri,1 E. Hicks,2 L. Kwan,1 S. Maliski,3 J. Veale.

    1Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; 2Oregon Health and Science University, Portland, OR; 3University of Kansas Medical Center School of Nursing, Kansas City, KS

    A. Non-directed donors (NDDs) can potentially help alleviate the overburdened kidney transplant waiting list while also improve the quality of life for patients with end-stage…
  • 2017 American Transplant Congress

    The Relationship Between Frailty and Decreased Physical Performance with Death on the Kidney Transplant Waiting List.

    E. Lorenz, F. Cosio, S. Bernard, S. Bogard, B. Bjerke, E. Geissler, S. Hanna, W. Kremers, M. Stegall, A. Cheville, N. LeBrasseur.

    Mayo Clinic, Rochester

    Background: Frailty and decreased physical performance are associated with poor outcomes after kidney transplant. Less is known about their relationship with pre-transplant outcomes. The aim…
  • 2017 American Transplant Congress

    When Does the Learning Curve End? A High-Volume Single Center Experience with Laparoscopic Donor Nephrectomy Over 16 Years.

    S. Yamanaga,1,2,3 A. Posselt,1 C. Freise,1 C. Niemann,1 A. Rosario,1 D. Fernandez,1 T. Kobayashi,3 A. Ahearn,4 M. Tavakol,1 S.-M. Kang.1

    1Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA; 2Department of General Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan; 3Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan; 4Department of Transplant Surgery, UMass Memorial Medical Center, Worcester, MA

    Purpose: No studies for any type of surgery have examined learning curves beyond a decade or 100 cases because surgeon turnover and lack of complete…
  • 2017 American Transplant Congress

    Risk Prediction Model for Delayed Graft Function in a Cohort of Brazilian Kidney Transplantation from Deceased Donors: What You See Is Not What You Get.

    S. Costa,1,2 T. Sandes-Freitas,1,2 E. Daher,2 R. Esmeraldo.1

    1Hospital Geral de Fortaleza, Fortaleza, Brazil; 2Federal University of Ceara, Fortaleza, Brazil

    Introduction: The estimated frequency of delayed graft function (DGF) in Brazil ranges from 50 to 70%, despite deceased donor and recipient characteristics similar to those…
  • 2017 American Transplant Congress

    Alemtuzumab Induction Is Safe, and Permits the Avoidance of Steroids in the Majority of Renal Transplant Recipients.

    A. Seitz,1 M. Robb,2 N. Ahmad,1 A. McLean,3 D. Taube,3 R. Johnson,2 R. Baker.1

    1Renal Unit, St James's Hospital, Leeds, United Kingdom; 2Organ Donation and Transplantation Studies, NHS Blood and Transplant, Bristol, United Kingdom; 3West London Renal and Transplant, Hammersmith Hospital, London, United Kingdom

    IntroductionThe introduction of alemtuzumab into routine clinical use has been hindered by safety concerns surrounding its prolonged effect on the lymphoid compartment. Here we report…
  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences